Four years after buying exclusive US rights to GAIA's digital therapeutic to help people with depression, Swedish drugmaker Orexo has terminated the deal. Deprexis is an online cognitive behavioural ...
Kyorin Pharma has signed a deal with digital health firm Hyfe to develop a digital therapeutic (DTx) for people with chronic cough and launch it in Japan. Hyfe's platform uses artificial intelligence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback